0001628280-24-050542.txt : 20241209 0001628280-24-050542.hdr.sgml : 20241209 20241209203933 ACCESSION NUMBER: 0001628280-24-050542 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241206 FILED AS OF DATE: 20241209 DATE AS OF CHANGE: 20241209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kallebo Lisa Michelle CENTRAL INDEX KEY: 0002000724 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39071 FILM NUMBER: 241536846 MAIL ADDRESS: STREET 1: C/O ADC THERAPEUTICS SA STREET 2: BIOPOLE ROUTE DE LA COMICHE 3B CITY: EPALINGES STATE: V8 ZIP: 1066 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADC Therapeutics SA CENTRAL INDEX KEY: 0001771910 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BIOPOLE STREET 2: ROUTE DE LA CORNICHE 3B CITY: EPALINGES STATE: V8 ZIP: 1066 BUSINESS PHONE: 41 21 653 02 00 MAIL ADDRESS: STREET 1: BIOPOLE STREET 2: ROUTE DE LA CORNICHE 3B CITY: EPALINGES STATE: V8 ZIP: 1066 4 1 wk-form4_1733794766.xml FORM 4 X0508 4 2024-12-06 0 0001771910 ADC Therapeutics SA ADCT 0002000724 Kallebo Lisa Michelle 430 MOUNTAIN AVENUE, SUITE 404 NEW PROVIDENCE NJ 07974 0 1 0 0 Chief Accounting Officer 0 Common Shares 2024-12-06 4 F 0 6503 3.13 D 35997 D Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted. /s/ Lisa Kallebo 2024-12-09